FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
FTC Sues CVS, Cigna, UnitedHealth over insulin prices
The enforcement action is part of an escalating conflict between the FTC and the three pharmacy benefit managers that ...
American Pharmacists Association applauds FTC action on PBMs' alleged inflation of insulin drug prices
Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically ...
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.